Similarly, lncRNA 00922 recruited three DNMTs in the NKD2 promoter to trigger NKD2 methylation and repress its expression, contributing to activation of Wnt signaling pathway and breast cancer progression (Wang et al., 2021). This evidence concerns the gene NKD2 and breast carcinoma.